Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trialG. Diodati, A. Ruol, Paola Bonetti et al.|Hepatology|1994Cited by 73
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trialGerardo Rosati, Roberto Labianca, Michele Prisciandaro et al.|Gastric Cancer|2022Cited by 4